.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
CLOVERS compared two early resuscitation strategies in patients with sepsis-induced hypotension: a restrictive approach that prioritised vasopressors and limited additional fluids, and a liberal approach that prioritised more intravenous fluid before escalating vasopressor support. The trial enrolled patients after an initial period of fluid treatment and followed them to 90 days. Mortality before discharge home by day 90 did not differ significantly between the strategies, and serious adverse-event rates were similar. The findings are useful because they shift the clinical question away from “How many litres should every patient receive?” toward “Which intervention best matches this patient's physiology right now?” Some patients may need additional fluid, while others may have persistent vasodilation and benefit more from vasopressors. The study does not prove that fluids and vasopressors are interchangeable; rather, it demonstrates that two intentionally different resuscitation approaches can produce similar overall outcomes when applied carefully. For clinicians, CLOVERS supports individualised haemodynamic assessment, attention to fluid tolerance and early recognition that ongoing hypotension is not always a sign of inadequate intravascular volume. It also reinforces the importance of avoiding therapeutic inertia—continuing fluids simply because hypotension persists without reassessing the underlying mechanism.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
CLOVERS compared two early resuscitation strategies in patients with sepsis-induced hypotension: a restrictive approach that prioritised vasopressors and limited additional fluids, and a liberal approach that prioritised more intravenous fluid before escalating vasopressor support. The trial enrolled patients after an initial period of fluid treatment and followed them to 90 days. Mortality before discharge home by day 90 did not differ significantly between the strategies, and serious adverse-event rates were similar. The findings are useful because they shift the clinical question away from “How many litres should every patient receive?” toward “Which intervention best matches this patient's physiology right now?” Some patients may need additional fluid, while others may have persistent vasodilation and benefit more from vasopressors. The study does not prove that fluids and vasopressors are interchangeable; rather, it demonstrates that two intentionally different resuscitation approaches can produce similar overall outcomes when applied carefully. For clinicians, CLOVERS supports individualised haemodynamic assessment, attention to fluid tolerance and early recognition that ongoing hypotension is not always a sign of inadequate intravascular volume. It also reinforces the importance of avoiding therapeutic inertia—continuing fluids simply because hypotension persists without reassessing the underlying mechanism.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
4 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
